Click here to read the article: https://gaincharity.org.uk/wp-content/uploads/2021/11/Patone-2021-Nature-medicine-ChAdOx1-and-GBS-Bells.pdf
Please read the Small Charities Coalition weekly newsletter from 16th November 2021, containing their latest COVID-19 update: SCC’s Newsletter 16th November (mailchi.mp)
The antiviral Lagevrio (molnupiravir) is safe and effective at reducing the risk of hospitalisation and death in people with mild to moderate COVID-19 who are at increased risk of developing severe disease, the Medicines and Healthcare products Regulatory Agency (MHRA) announced today. This follows a rigorous review of its safety, quality and effectiveness by the […] Read More
The risks of developing neurological complications following Covid-19 infection ‘are much greater’ than those associated with Covid-19 vaccinations, according to a UK-based study led by the University of Oxford. In one of the most extensive population-based studies to examine the risk of developing adverse neurological reactions in response to Covid vaccinations, the researchers found neurological […] Read More
Emerging reports of rare neurological complications associated with COVID-19 infection and vaccinations are leading to regulatory, clinical and public health concerns. We undertook a self-controlled case series study to investigate hospital admissions from neurological complications in the 28 days after a first dose of ChAdOx1nCoV-19 (n = 20,417,752) or BNT162b2 (n = 12,134,782), and after a SARS-CoV-2-positive test (n = 2,005,280). There […] Read More
Getting the right care, treatment and support at the right time can make a life-changing difference when you have a neurological condition, like GBS or CIDP. But there are huge variations across the UK – not everyone with a neurological condition in the UK has access to the same high quality, joined up care and […] Read More
Read the latest NHS guidance on vaccinations this winter: https://www.nhs.uk/conditions/vaccinations/flu-influenza-vaccine/
Rev Neurol. 2021 Oct 16;73(8):275-281. doi: 10.33588/rn.7308.2021261. ABSTRACT INTRODUCTION: Patients with CIDP respond adequately to steroid therapy and intravenous immunoglobulin (IVIG). However, few patients have access to IVIG in developing countries. Little information exists about the clinical response to steroid therapy in Latin American countries. OBJECTIVE: to describe the long-term functional clinical response (24 months) […] Read More
The public are being reminded to come forward for their flu jab to maximise their protection ahead of winter. Health officials are worried because this will be the first winter Covid and flu circulate fully at the same time. Research shows those infected with both viruses are more than twice as likely to die as […] Read More
The government has agreed to end the requirement for shielding guidance for people previously considered to be clinically extremely vulnerable. People previously considered to be clinically extremely vulnerable will not be advised to shield again, as the government agrees to end the requirement for centralised guidance for these groups following expert clinical advice. The closure […] Read More